ALNY

Q: What is the price of Alnylam Pharmaceuticals (ALNY) today?

The price of Alnylam Pharmaceuticals (ALNY) today is R$ 2.445,50, with a variation of 60.99% compared to the last year. The price of Alnylam Pharmaceuticals (ALNY) started the year trading around R$ 0,00 and today it is at R$ 2.445,50. Follow the real-time price chart, the historical price of Alnylam Pharmaceuticals (ALNY), and stock data from Ibovespa and international markets.

Q: When does Alnylam Pharmaceuticals (ALNY) pay dividends?

Alnylam Pharmaceuticals (ALNY) did not distribute dividends in the last year.

Q: Alnylam Pharmaceuticals (ALNY) is it worth it?

Currently, Alnylam Pharmaceuticals (ALNY) is priced at R$ 2.445,50, with a P/E of -186,54%, representing a deviation of -80,03% from its historical average P/E. In the last year, the stock showed a variation of 60.99% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 60,99%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Alnylam Pharmaceuticals (ALNY)?

Investing in shares of Alnylam Pharmaceuticals (ALNY) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Alnylam Pharmaceuticals (ALNY) yield today?

The yield of Alnylam Pharmaceuticals (ALNY) was 37,22% in the last month, 60,99% in the last year and 243,35% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Alnylam Pharmaceuticals (ALNY) today, the total investment would be based on the current price of R$ 2.445,50.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 393.701,69In 5 years: R$ 839.663,80In 10 years: 1.072.206,77It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Alnylam Pharmaceuticals Inc.

Price

US$ 451,20

variation (12m)

60,99%

p/l

-186,54

p/vp

237,53

DIVIDEND YIELD

0,00%

quote ALNY

BVMF

ALNY

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of ALNY

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

37,22%

3 months

58,01%

1 year

60,99%

2 years

135,42%

5 years

243,35%

10 years

338,44%

real profitability

profitability minus inflation.

1 month

37,22%

3 months

57,22%

1 year

52,97%

2 years

114,59%

5 years

150,89%

10 years

159,92%

Indicators ALNY

check out the fundamentals of Alnylam Pharmaceuticals shares

P/L

-186,54

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

24,18

Sector: -3,77 Industry: -3,77

P/VP

237,53

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-6,99%

Sector: -63,50% Industry: -63,50%

ROE

-127,34%

Sector: -67,23% Industry: -67,23%

ROIC

-10,03%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

-12,96%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

83,64%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

-7,32%

Sector: -43,21% Industry: -43,21%

P/EBITDA

-346,17

Sector: -3,13 Industry: -3,13

P/EBIT

-261,83

Sector: -3,41 Industry: -3,41

P/ASSETS

13,04

Sector: 1,29 Industry: 1,29

VPA

1,91

Sector: 1,80 Industry: 1,80

LPA

-2,44

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,05

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

37,95%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-17,95%

Sector: - Industry: -

ALNY indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of ALNY with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history ALNY dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc.

Average user rating I10

4.0 (1 people)

Estados Unidos

22 years

Foundation: 2003

2004

Year of debut on the stock exchange - 21 years

1.453

Employees

The Company Alnylam Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 59,52 Billions, having a net worth of $ 250,59 Milhões.

With a total of 1.453 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 2,46 Billions, which generated a loss in the amount of $ -319,09 Milhões.

As for its main indicators, the Company has a P/E ratio of -186,54, a P/B ratio of 237,53 and in the last 12 months the Company did not pay dividends.

The Company is traded in Brazil through the BDR A1LN34, or can be purchased on abroad through the ticker ALNY.

Market value

US$ 59,52 Billions

Net worth

US$ 250,59 Milhões

US$ 250.590.000,00

Assets

US$ 4,57 Billions

US$ 4.566.020.000,00

Total Number of Shares

131,00 Milhões

131.000.000

Average Daily Trading Volume

US$ 1,09 Million

US$ 1.094.068,00

Sector

Cuidados de saúde

Industry

Biotecnologia

ALNY

ALNY revenue and profits

ALNY results

DRAG THE FRAME TO SEE MORE DATA

ALNY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Alnylam Pharmaceuticals (ALNY) today?

The price of Alnylam Pharmaceuticals (ALNY) today is R$ 2.445,50, with a variation of 60.99% compared to the last year. The price of Alnylam Pharmaceuticals (ALNY) started the year trading around R$ 0,00 and today it is at R$ 2.445,50. Follow the real-time price chart, the historical price of Alnylam Pharmaceuticals (ALNY), and stock data from Ibovespa and international markets.

When does Alnylam Pharmaceuticals (ALNY) pay dividends?

Alnylam Pharmaceuticals (ALNY) did not distribute dividends in the last year.

Alnylam Pharmaceuticals (ALNY) is it worth it?

Currently, Alnylam Pharmaceuticals (ALNY) is priced at R$ 2.445,50, with a P/E of -186,54%, representing a deviation of -80,03% from its historical average P/E. In the last year, the stock showed a variation of 60.99% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 60,99%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Alnylam Pharmaceuticals (ALNY)?

Investing in shares of Alnylam Pharmaceuticals (ALNY) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Alnylam Pharmaceuticals (ALNY) yield today?

The yield of Alnylam Pharmaceuticals (ALNY) was 37,22% in the last month, 60,99% in the last year and 243,35% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Alnylam Pharmaceuticals (ALNY) today, the total investment would be based on the current price of R$ 2.445,50.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 393.701,69
In 5 years: R$ 839.663,80
In 10 years: 1.072.206,77

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ALNY

Alnylam Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of ALNY

check out the fundamentals of Alnylam Pharmaceuticals shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc.

Estados Unidos

22 years

2004

1.453

PROFIT X PRICE ALNY

ALNY results

ALNY cash flow

evolution of assets - ALNY

ALNY balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80